Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Langetermijnresultaten bevestigen fase III-data van cladribine (ECTRIMS 2019 in Stockholm)
okt 2019 | Multipele Sclerose